Cryopreservation of reproductive tissue – the possibility of preserving fertility (a review)

Close metadata

Recommended articles:

Non-hormonal methods of treating premature ovarian insufficiency (POI). Russian Journal of Human Reproduction. 2024;(2):6-14

Profile of serum autoantibodies in women with premature ovarian insufficiency receiving complex treatment using new surgical technologies. Russian Journal of Human Reproduction. 2024;(2):32-41

Dynamics of the condition of patients with premature ovarian insufficiency and the autoantibody profile before and after the use of new surgical technologies in complex treatment. Russian Journal of Human Reproduction. 2024;(5):25-34

The role of ferroptosis in reproduction. A modern view of the problem. Russian Journal of Human Reproduction. 2024;(5):35-45

The syndrome of psycho-sensory-anatomical-functional auto-desadaptation in patients with malignant tumors of the maxillofacial region. Stomatology. 2024;(4):20-27

In the modern world, there is an increasing trend when healthy women postpone pregnancy and childbirth for social reasons. It is reliably known that with increasing age, the possibility of spontaneous conception is sharply reduced. We should not forget about premature ovarian failure, which in 10% of cases has a «dumb» picture. For women, the implementation of the reproductive function is one of the most important tasks in life. Premature ovarian failure is considered by each woman as a personal tragedy, combining not only the impossibility of conception, but also the corresponding endocrine disorders. The concept of «fertility preservation» first appeared in oncology, where, to improved methods of diagnosis and treatment, the long-term survival of young patients with malignant tumors of various localities has improved. However, treatment can lead to premature exhaustion and ovarian failure. The possibilities of modern assisted reproductive technologies have increased significantly with the introduction into practice of one of the important and promising methods of preserving fertility — cryopreservation of reproductive tissue with its subsequent transplantation. Initially, it was proposed to preserve fertility in cancer patients who were to undergo gonadotoxic therapy, however, it was later used in patients with premature ovarian failure of various origins. Abroad, this method has been used for over 20 years, a large network of cryobanks has been created. In this review, we present data on the modern possibilities of using the method of cryopreservation of reproductive tissue with its subsequent transplantation in order to restore fertility in case of premature ovarian failure of various origins. The review also presents the experience of cryobanks of reproductive tissue in Israel, USA, England — one of the largest in the world. Special attention is paid to the issues of ovarian tissue allotransplantation, which, according to studies, can help patients with autoimmune diseases, Turner syndrome, and genetic forms of premature ovarian failure.

Keywords:

premature ovarian failure

malignant tumors

reproductive tissue cryopreservation

cryobank

ovarian tissue transplantation

ovarian tissue allotransplantation

fertility preservation

Authors:

Yupatov E.Yu.

Kazan State Medical Academy — branch of the Russian Medical Academy of Continuous Professional Education;
Kazan (Volga region) Federal University

ORCID: 0000-0001-8945-8912

Kurmanbaev T.E.

Military Medical Academy named after S.M. Kirov

ORCID: 0000-0003-0644-5767

Shmidt A.A.

Kirov Military Medical Academy

Timoshkova Yu.L.

Kirov Military Medical Academy

Galimova I.R.

University hospital of Kazan (Volga region) Federal University

Received:

21.04.2020

Accepted:

06.08.2020

List of references:

Gleicher N, Kushnir AV, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reproductive Biology and Endocrinology: RB&E. 2015;13:34. https://doi.org/10.1186/s12958-015-0026-z
Donnez J. Introduction: fertility preservation, from cancer to benign disease to social reasons: the challenge of the present decade. Fertility and Sterility. 2013;99(6):1467-1468. https://doi.org/10.1016/j.fertnstert.2013.03.040.
Cobo A, Garcia-Velasco JA, Domingo J, Remohl J, Pellicer A. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertility and Sterility. 2013; 99(6):1485-1495. https://doi.org/10.1016/j.fertnstert.2013.02.050
Argyle CE, Harper JC, Davies MC. Oocyte cryopreservation: where are we now? Human Reproduction Update. 2016;22(4):440-449. https://doi.org/10.1093/humupd/dmw007
Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reproductive Biology and Endocrinology: RB&E. 2011;9:23. https://doi.org/10.1186/1477-7827-9-23
Adamyan LV, Dementieva VO, Smolnikova VYu, Asaturova AV. New surgical ways to recover lost ovarian functions in premature ovarian insufficiency in women of reproductive age. Doctor.Ru. 2019;11(166): 44-49. (In Russ.). https://doi.org/10.31550/1727-2378-2019-166-11-44-49
Zhai J, Yao G, Dong F, Bu Z, Cheng Y, Sato Y, Hu L, Zhang Y, Wang J, Dai S, Li J, Sun J, Hsueh AJ, Kawamura K, Sun Y. In vitro activation of follicles and fresh tissue auto-transplantation in primary ovarian insufficiency patients. The Journal of Clinical Endocrinology and Metabolism. 2016;101(11):4405-4412. https://doi.org/10.1210/jc.2016-1589
Ye M, Yeh J, Kosteria I, Li L. Progress in fertility preservation strategies in turner syndrome. Frontiers in Medicine. 2020;7:3. https://doi.org/10.3389/fmed.2020.00003
American Society for Reproductive Medicine. Mature oocyte cryopreservation: a guideline. Fertility and Sterility. 2013;99(1):37-43. https://doi.org/10.1016/j.fertnstert.2012.09.028
Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884-886. https://doi.org/10.1016/s0140-6736(86)90989-x
Rodriguez-Wallberg KA, Waterstone M, Anastácio A. Ice age: cryopreservation in assisted reproduction — an update. Reproductive Biology. 2019;19(2):119-126. https://doi.org/10.1016/j.repbio.2019.04.002
Zhang X, Niu J, Che T, Zhu Y, Zhang H, Qu J. Fertility preservation in BRCA mutation carriers — efficacy and safety issues: a review. Reproductive Biology and Endocrinology: RB&E. 2020;18(1):11. https://doi.org/10.1186/s12958-019-0561-0
Arav A, Patrizio P. Techniques of cryopreservation for ovarian tissue and whole ovary. Clinical Medicine Insights: Reproductive Health. 2019;13:1-5. https://doi.org/10.1177/1179558119884945
Shapira M, Raanani H, Meirow D. IVF for fertility preservation in breast cancer patients — efficacy and safety issues. Journal of Assisted Reproduction and Genetics. 2015;32(8):1171-1178. https://doi.org/10.1007/s10815-015-0519-x
Vuković P, Kasum M, Raguž J, Lonjak N, Bilić Knežević S, Orešković I, Beketić Orešković L. Fertility preservation in young women with early-stage breast cancer. Acta Clinica Croatica. 2019;58(1):147-156. https://doi.org/10.20471/acc.2019.58.01.19
Ter Welle-Butalid MEE, Vriens IJHI, Derhaag JGJ, Leter EME, de Die-Smulders CEC, Smidt MM, van Golde RJTR, Tjan-Heijnen VCGV. Counseling young women with early breast cancer on fertility preservation. Journal of Assisted Reproduction and Genetics. 2019; 36(12):2593-2604. https://doi.org/10.1007/s10815-019-01615-6
Fabregues F, Ferreri J, Calafell JM, Moreno V, Borrás A, Manau D, Carmona F. Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review. Journal of Ovarian Research. 2018;11(1):76. https://doi.org/10.1186/s13048-018-0447-3
Sheshpari S, Shahnazi M, Mobarak H, Ahmadian S, Bedate AM, Nariman-Saleh-Fam Z, Nouri M, Rahbarghazi R, Mahdipour M. Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review. Journal of Translational Medicine. 2019;17(1):396. https://doi.org/10.1186/s12967-019-02149-2
Callejo J, Salvador C, Miralles A, Vilaseca S, Lailla JM, Balasch J. Long-term ovarian function evaluation after autografting by implantation with fresh and frozen-thawed human ovarian tissue. The Journal of Clinical Endocrinology and Metabolism. 2001;86(9):4489-4494. https://doi.org/10.1210/jcem.86.9.7871
Fabbri R, Pasquinelli G, Magnani V, Macciocca M, Vicenti R, Parazza I, Paradisi R, Battaglia C, Rossi S, Venturoli S. Autotransplantation of cryopreserved ovarian tissue in oncological patients: recovery of ovarian function. Future Oncology (London, England). 2014;10(4):549-561. https://doi.org/10.2217/fon.13.234
Beckmann MW, Dittrich R, Lotz L, Oppelt PG, Findeklee S, Hildebrandt T, Heusinger K, Cupisti S, Müller A. Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience. Archives of Gynecology and Obstetrics. 2017;295(4):1033-1039. https://doi.org/10.1007/s00404-017-4311-2
Póvoa A, Xavier P, Calejo L, Soares S, Sousa M, Silva J, Sousa S, Barros A, Beires J. First transplantation of cryopreserved ovarian tissue in Portugal, stored for 10 years: an unexpected indication. Reproductive Biomedicine Online. 2016;32(3):334-336. https://doi.org/10.1016/j.rbmo.2015.12.002
Müller A, Keller K, Wacker J, Dittrich R, Keck G, Montag M, Van der Ven H, Wachter D, Beckmann MW, Distler W. Retransplantation of cryopreserved ovarian tissue: the frst live birth in Germany. Deutsches Arzteblatt International. 2012;109(1-2):8-13. https://doi.org/10.3238/arztebl.2012.0008
Donfack NJ, Alves KA, Araújo VR, Cordova A, Figueiredo JR, Smitz J, Rodrigues APR. Expectations and limitations of ovarian tissue transplantation. Zygote (Cambridge, England). 2017;25(4): 391-403. https://doi.org/10.1017/S0967199417000338
Lakhoo K, Davies J, Chakraborty S, Berg S, Tennyson R, Fowler D, Manek S, Verrill C, Lane S. Development of a new reproductive tissue cryopreservation clinical service for children: the Oxford programme. Pediatric Surgery International. 2019;35(11): 1271-1278. https://doi.org/10.1007/s00383-019-04503-3
Giudice MG, de Michele F, Poels J, Vermeulen M, Wyns C. Update on fertility restoration from prepubertal spermatogonial stem cells: how far are we from clinical practice? Stem Cell Research. 2017;21:171-177. https://doi.org/10.1016/j.scr.2017.01.009
Stukenborg JB, Alves-Lopes JP, Kurek M, Albalushi H, Reda A, Keros V, Töhönen V, Bjarnason R, Romerius P, Sundin M, Norén Nyström U, Langenskiöld C, Vogt H, Henningsohn L, Mitchell RT, Söder O, Petersen C, Jahnukainen K. Spermatogonial quantity in human prepubertal testiculat tissue collected for fertility preservation prior to potentially sterilizing therapy. Human Reproduction (Oxford, England). 2018;33(9):1677-1683. https://doi.org/10.1093/humrep/dey240
Wallace WH, Kelsey TW, Anderson RA. Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation. Fertility and Sterility. 2016;105(1):6-12. https://doi.org/10.1016/j.fertnstert.2015.11.041
Silber JS, DeRosa M, Goldsmith S, Fan Y, Castleman L, Melnick J. Cryopreservation and transplantation of ovarian tissue: results from one center in the USA. Journal of Assisted Reproduction and Genetics. 2018;35(12):2205-2213. https://doi.org/10.1007/s10815-018-1315-1
Silber SJ, Lenahan KM, Levine DJ, Pineda JA, Gorman KS, Friez MJ, Crawford EC, Gosden RG. Ovarian transplantation between monozygotic twins discordant for pre-mature ovarian failure. The New England Journal of Medicine. 2005;353(1):58-63. https://doi.org/10.1056/NEJMoa043157
Meirow D, Ra’anani H, Shapira M, Brenghausen M, Derech Chaim S, Aviel-Ronen S, Amariglio N, Schiff E, Orvieto R, Dor J. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertility and Sterility. 2016;16(2):462-474. https://doi.org/10.1016/j.fertnstert.2016.04.031
Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. The New England Journal of Medicine. 2005;353(3):318-321. https://doi.org/10.1056/NEJMc055237
Dolmans MM, Jadoul P, Gilliaux S, Amorim CA, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A. A review of 15 years of ovarian tissue bank activities. Journal of Assisted Reproduction and Genetics. 2013;30(3):305-314. https://doi.org/10.1007/s10815-013-9952-x
Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertility and Sterility. 2013;99(6):1503-1513. https://doi.org/10.1016/j.fertnstert.2013.03.030
Abakushina EV, Otoi T, Kaprin AD. Recovery options of reproductive function of cancer patients due to transplantation of cryopreserved ovarian tissue. Geny i kletki. 2015;10(1):18-27. (In Russ.).
Bystrova OV, Lapina EN, Kalugina AS, Lisyanskaya AS, Manikhas GM. Spontaneous pregnancy after transplantation of cryopreserved ovarian tissue: a case report. Problemy reproduktsii. 2019;25(2): 51-54. (In Russ.). https://doi.org/10.17116/repro20192502151
Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S, Sugishita Y, Morimoto Y, Hosoi Y, Yoshioka N, Ishizuka B, Hsueh AJ. Hippo signaling disruption and akt stimulation of ovarian follicles for infertility treatment. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(43):17474-17479. https://doi.org/10.1073/pnas.1312830110

Close metadata